Shuang B. Ye

325 Guohe Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 220 publications

From 'Me too' to 'Me better' and 'Me cooler': the recent rheumatology advances in China.

From 'Me too' to 'Me better' and 'Me cooler': the recent rheumatology advances in China.

Journal: EULAR rheumatology open

Published: August 01, 2026

Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline.

Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline.

Journal: Seminars in arthritis and rheumatism

Published: June 09, 2026

Mapping the synovial immune ecosystem in rheumatoid arthritis: cellular cartography and pathotype-guided immune restoration.

Mapping the synovial immune ecosystem in rheumatoid arthritis: cellular cartography and pathotype-guided immune restoration.

Journal: Current opinion in immunology

Published: May 06, 2026

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 10, 2026

Discovery of novel hydroxime-based NLRP3 inflammasome inhibitors with reduced hepatotoxicity.

Discovery of novel hydroxime-based NLRP3 inflammasome inhibitors with reduced hepatotoxicity.

Journal: Bioorganic & medicinal chemistry letters

Published: January 05, 2026

Upadacitinib Versus Tofacitinib in Anti-MDA5-Positive Dermatomyositis With Interstitial Lung Disease: A Multi-Centre Cohort Study Emulating a Target Trial.

Upadacitinib Versus Tofacitinib in Anti-MDA5-Positive Dermatomyositis With Interstitial Lung Disease: A Multi-Centre Cohort Study Emulating a Target Trial.

Journal: Respirology (Carlton, Vic.)

Published: December 26, 2025

Correction: Obinutuzumab in systemic lupus erythematosus: a real-world experience.

Correction: Obinutuzumab in systemic lupus erythematosus: a real-world experience.

Journal: Frontiers in immunology

Published: December 10, 2025

A Novel Tool for Predicting Malignant Disease in Adult Patients With Dermatomyositis.

A Novel Tool for Predicting Malignant Disease in Adult Patients With Dermatomyositis.

Journal: JAMA dermatology

Published: December 03, 2025

Quetiapine inhibits the oxidative phosphorylation in head and neck squamous cell carcinoma through suppressing NAT10-mediated ac4C modification.

Quetiapine inhibits the oxidative phosphorylation in head and neck squamous cell carcinoma through suppressing NAT10-mediated ac4C modification.

Journal: Translational cancer research

Published: December 01, 2025

Arthroscopic Guided Synovectomy, Synovial Biopsies, and Pathotype Identification in Refractory Rheumatoid Arthritis.

Arthroscopic Guided Synovectomy, Synovial Biopsies, and Pathotype Identification in Refractory Rheumatoid Arthritis.

Journal: Journal of visualized experiments : JoVE

Published: November 24, 2025

Twenty-four months progression-free survival (ongoing) for treatment of recurrent ovarian clear cell carcinoma with surufatinib in combination with toripalimab: a case report.

Twenty-four months progression-free survival (ongoing) for treatment of recurrent ovarian clear cell carcinoma with surufatinib in combination with toripalimab: a case report.

Journal: BMC women's health

Published: November 10, 2025

Recurrent macrophage activation syndrome in patients with refractory systemic lupus erythematosus treated with emapalumab: a case report.

Recurrent macrophage activation syndrome in patients with refractory systemic lupus erythematosus treated with emapalumab: a case report.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: October 20, 2025

Showing 1-12 of 220

Last Updated: 09/26/2026